EraGen Partners with Illumina to Develop Molecular Dx Assays

The companies will develop molecular-based, high-throughput, clinical assays using Eragen's MultiCode-PLx technology and Illumina's BeadXpress platform.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.